SCHEMBL6857398

SCHEMBL6857398

FC(F)(F)c1ccc(SCC2CCCN2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.49
HRH3 Q9Y5N1 4/20 0.39
HRH1 P35367 2/20 0.39
HRH4 Q9H3N8 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTR6 P50406 2/20 0.38
HTR2C P28335 2/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
SCN9A Q15858 1/20 0.37
DAO P14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5168025 1.00 LTA4H (0.49) LTA4HHRH3HRH1HRH4CYP3A4
Hydrochloric Acid SCHEMBL4742878 0.78 POLB (0.49) LTA4HHTR6CRBN
SCHEMBL22456442 0.76 POLB (0.56) LTA4HHTR6HTR2CIDO1TDO2
SCHEMBL10132546 0.76 POLB (0.56) LTA4HHTR6HTR2CIDO1TDO2
SCHEMBL26448460 0.75 HTR2C (0.51) HRH3HRH1HRH4CYP3A4CYP2D6
SCHEMBL10794749 0.75 LTA4H (0.51) LTA4HCRBN
SCHEMBL9078944 0.74 POLB (0.57) LTA4HHRH1CYP3A4CYP2D6CYP2C19
Bromide SCHEMBL10799026 0.74 LTA4H (0.50) LTA4HCRBN
SCHEMBL4307734 0.74 LTA4H (0.58) LTA4H
SCHEMBL4307738 0.74 LTA4H (0.58) LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US disclosed